Webinar: RADx Tech Accessible Tests Program Best Practices - CIMIT MAIN

Responsive Image

We are thrilled to announce that we’ve been selected as one of the first spokes of the ARPA-H Investor Catalyst Hub network!

We are excited to be a part of this nationwide network dedicated to accelerating groundbreaking advances in science and medicine—all in pursuit of better health outcomes for everyone.

Learn more >

Funding Opportunities and Events

News and Annoucements

null Webinar: RADx Tech Accessible Tests Program Best Practices

Webinar: RADx Tech Accessible Tests Program - Best Practices

Since the Spring of 2022, RADx Tech has been working to make COVID-19 home tests more accessible (our previous webinar addressed these efforts). During this work, the team has also captured what we've learned (from knowledgeable evaluators, designers, SMEs and vendors in the field) in a best practices document. While a comprehensive document is anticipated this Spring, an early edition of these best practices, with insights so far, was published in December, with support from NIH, on the US Access Board website site. While it is based on COVID test development, we hope it will have future applications across the field of home test design.

Speakers:  
Brian Walsh 
RADx Tech Accessibility Program Manager, Deployment Core Team Lead

Clair O’Donovan, PhD
RADx Tech Team Leader

John Blackwood
RADx Team Leader

When: 
February 28th, 2023
2PM ET

Watch the recording >

Download the slides >

If you need assistance registering for this webinar please call 617-643-3800 or email cimitcommunications@partners.org.

Connect with Us

Our Lasting Impact

As an early pioneer in managing translational research, CIMIT has directly supported over 1,200 innovator teams and reviewed or consulted on over 5,000 ideas since our founding in 1998.

We work collaboratively with healthtech innovators, entrepreneurs, and institutions to ultimately make a positive impact on patient care across the globe. We streamline pathways to progress through our efficient processes, established systems, and unparalleled market expertise.